【同仁堂国药(03613.HK)发布年度业绩 股东应占溢利5亿港元 同比减少7.4%】同仁堂国药(03613.HK)发布截至2024年12月31日止年度业绩,收入16.12亿港元,同比增加5.7%;股东应占溢利5亿港元,同比减少7.4%;每股基本盈利0.6港元,拟派发末期股息每股0.35港元。

金融界
28 Mar
同仁堂国药(03613.HK)发布截至2024年12月31日止年度业绩,收入16.12亿港元,同比增加5.7%;股东应占溢利5亿港元,同比减少7.4%;每股基本盈利0.6港元,拟派发末期股息每股0.35港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10